CONMED Corporation Announces Third Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
CONMED (CNMD) PT Raised to $58 at Needham & Company Following 3Q Report
November 3, 2017 8:29 AM EDTNeedham & Company raised its price target on CONMED (NASDAQ: CNMD) to $58.00 (from $57.00) while maintaining a Buy rating following the company's 3Q release. Revenue was $190.1M vs. consensus of $187.1M and EPS was $0.42 vs. consensus of $0.41. lower than expected tax rate added ~$0.03 to... More
Conmed (CNMD) Tops Q3 EPS by 1c
November 2, 2017 4:19 PM EDTConmed (NASDAQ: CNMD) reported Q3 EPS of $0.42, $0.01 better than the analyst estimate of $0.41. Revenue for the quarter came in at $190.1 million versus the consensus estimate of $187.08 million.
For earnings history and earnings-related data on Conmed (CNMD) click here.
... More


